HIGHLIGHTS
- who: Strahlenther Onkol and colleagues from the Survey distribution Altogether, clinical centers located in Europe were approached that apply superficial, deep, and whole-body HT for treating cancer patientsFrom each center, the head of the HT facility was contacted and invited to participate. Participants were only allowed to answer the survey once. The HT centers included in the survey are the clinical centers of the Hyperboost consortium (Cantonal Hospital Aarau, Charité Universitätsmedizin Berlin, University Hospital Erlangen, Erasmus University Medical Center, Amsterdam University Medical Centers, University Hospital Aarhus) and, in addition, other major European HT centers (Ludwig . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.